Member of the European Molecular Biology Organization (EMBO)
Immunology, T cell, Cytotoxic T cell, Cancer immunotherapy and Interleukin 17 are his primary areas of study. Immunology connects with themes related to Cancer in his study. His work on Antigen-presenting cell is typically connected to B-cell leukemia as part of general T cell study, connecting several disciplines of science.
His work focuses on many connections between Antigen-presenting cell and other disciplines, such as Interleukin 21, that overlap with his field of interest in Interleukin 12. His work carried out in the field of Cytotoxic T cell brings together such families of science as BCL10, CD8 and Cell biology. His studies in Cancer immunotherapy integrate themes in fields like Antigen and Cytotoxicity.
His primary areas of study are Immunology, T cell, Cell biology, Immune system and Cytotoxic T cell. His biological study spans a wide range of topics, including Tumor microenvironment, Cellular differentiation and Antigen. Bruno Silva-Santos has included themes like Receptor, microRNA, CD8 and T-cell receptor in his Cell biology study.
His studies deal with areas such as Proinflammatory cytokine and Cytokine as well as Immune system. His Cytotoxic T cell research is multidisciplinary, incorporating elements of Cancer research and Transcriptional regulation. The various areas that Bruno Silva-Santos examines in his IL-2 receptor study include Interleukin 21 and T lymphocyte.
Bruno Silva-Santos spends much of his time researching Immune system, Cell biology, T cell, Cancer research and Antigen. His Immune system research is multidisciplinary, relying on both Synaptic plasticity and Central nervous system. His Cell biology research incorporates elements of CD8, T cell differentiation, microRNA, Regulation of gene expression and Epigenetics.
His T cell study also includes
Bruno Silva-Santos focuses on Cell biology, Antigen, Immune system, T cell and Cancer research. His Cell biology research incorporates themes from Interleukin 17, Neuroinflammation, T-cell receptor, Autoimmunity and Chemokine receptor. He has researched Antigen in several fields, including Receptor, Chimeric antigen receptor, Cancer immunotherapy and Cytotoxicity.
His Immune system study frequently draws connections between adjacent fields such as Cytotoxic T cell. His T cell research integrates issues from Tissue physiology, Tissue homeostasis, Central nervous system and Adipose tissue, Thermogenesis. His Cancer research study combines topics in areas such as Inflammation, Cancer cell, Cancer and Immune checkpoint.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets.
Julie C Ribot;Julie C Ribot;Ana deBarros;Ana deBarros;Dick John Pang;Joana F Neves;Joana F Neves.
Nature Immunology (2009)
γδ T cells in cancer.
Bruno Silva-Santos;Karine Serre;Håkan Norell.
Nature Reviews Immunology (2015)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Oncotarget (2014)
Lymphotoxin-mediated regulation of γδ cell differentiation by αβ T cell progenitors
Bruno Silva-Santos;Daniel J. Pennington;Adrian C. Hayday.
Science (2005)
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
Daniel V. Correia;Daniel V. Correia;Manuela Fogli;Kelly Hudspeth;Maria Gomes da Silva.
Blood (2011)
The inter-relatedness and interdependence of mouse T cell receptor γδ + and αβ + cells
Daniel J Pennington;Bruno Silva-Santos;John Shires;John Shires;Efstathios Theodoridis.
Nature Immunology (2003)
Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
Anita Q. Gomes;Duarte S. Martins;Bruno Silva-Santos.
Cancer Research (2010)
The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity
Telma Lança;Daniel V. Correia;Daniel V. Correia;Catarina F. Moita;Helena Raquel.
Blood (2010)
IL-17+ γδ T cells as kick-starters of inflammation.
Pedro H Papotto;Julie C Ribot;Bruno Silva-Santos.
Nature Immunology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
University of Milan
Federal University of Toulouse Midi-Pyrénées
Johannes Gutenberg University of Mainz
Leiden University Medical Center
Agency for Science, Technology and Research
The Francis Crick Institute
The Francis Crick Institute
University of Lisbon
University of Lausanne
Université Catholique de Louvain
City, University of London
Universitat Politècnica de Catalunya
Tsinghua University
Bohai University
University of Oxford
Hannover Medical School
Australian National University
University of Houston
Spanish National Research Council
Aristotle University of Thessaloniki
Yale University
Ludwig-Maximilians-Universität München
Université Laval
Rajasthan University of Health Sciences
University of Zurich